News
Should Value Investors Buy Heritage Insurance (HRTG) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Is Crown Holdings (CCK) Stock Undervalued Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Is Boyd Gaming (BYD) Outperforming Other Consumer Discretionary Stocks This Year?
For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Boyd Gaming (BYD) been one of those stocks
Wall Street Bulls Look Optimistic About Groupon (GRPN): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Core & Main (CNM) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Is Robinhood Markets (HOOD) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts See SentinelOne (S) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Brokers Suggest Investing in Fiverr (FVRR): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Wall Street Analysts See Netflix (NFLX) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Analysts Think Dutch Bros (BROS) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Here's What Key Metrics Tell Us About REV Group (REVG) Q3 Earnings
REV Group (REVG) reported $644.9 million in revenue for the quarter ended July 2025, representing a year-over-year increase of 11.3%. EPS of $0.79 for the same period compares to $0.48 a year ago.
Wall Street Analysts Look Bullish on Wingstop (WING): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
New to Investing? This 1 Finance Stock Could Be the Perfect Starting Point
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Campbell (CPB) Reports Q4 Earnings: What Key Metrics Have to Say
Campbell's (CPB) reported $2.32 billion in revenue for the quarter ended July 2025, representing a year-over-year increase of 1.2%. EPS of $0.62 for the same period compares to $0.63 a year ago.
The
Wall Street Bulls Look Optimistic About JPMorgan Chase & Co. (JPM): Should You Buy?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
New to Investing? This 1 Business Services Stock Could Be the Perfect Starting Point
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Macy's (M) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended July 2025, Macy's (M) reported revenue of $4.81 billion, down 2.5% over the same period last year. EPS came in at $0.41, compared to $0.53 in the year-ago quarter.
The reported
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Dollar Tree (DLTR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended July 2025, Dollar Tree (DLTR) reported revenue of $4.57 billion, down 38.1% over the same period last year. EPS came in at $0.77, compared to $0.67 in the year-ago quarter.
The
PRIM Targets $2.5B in Renewables: Will Solar Growth Support Margins?
Primoris Services Corporation PRIM is on pace to deliver nearly $2.5 billion in renewables revenues in 2025, above its earlier outlook of $2.2-$2.3 billion. This upside has been fueled by strong
Micron Rides on DRAM Demand Wave: Can the AI Boom Keep Aiding Growth?
Micron Technology, Inc. MU is witnessing strong momentum from its DRAM business. The business unit’s revenues soared 51% year over year and 15% sequentially to $7.1 billion in the third quarter of
Dolby Vision 2 Unveils Next-Gen Picture Innovation for Modern Displays
Dolby Laboratories, Inc. (DLB) recently released Dolby Vision 2, the next-generation evolution of its superior picture quality innovation. For more than a decade, Dolby Vision has raised the bar for
Equity Residential Boosts Shareholder Confidence With Operating Update
In a major boost to investors’ sentiment, Equity Residential EQR recently provided an update highlighting positive same-store operating trends in its business. The residential REIT emphasized that
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise
QIAGEN N.V. QGEN announces the launch of QIAstat-Dx Rise — a version of the QIAstat-Dx automated syndromic testing system that offers enhanced throughput with the easiest workflow available to


